The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Jun. 8];6(6):s77. Available from: https://skin.dermsquared.com/skin/article/view/1835